S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

UNCY Unicycive Therapeutics Inc

0.6553

0.0353 (5.69%)

Last Updated: 13:30:41

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics Inc News

Form 8-K - Current report
Tuesday 7 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024
Monday 28 October 2024 (3 months ago) • GlobeNewswire Inc.

Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024
Wednesday 16 October 2024 (3 months ago) • GlobeNewswire Inc.

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024
Monday 14 October 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 11 October 2024 (3 months ago) • Edgar (US Regulatory)

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
Wednesday 9 October 2024 (3 months ago) • GlobeNewswire Inc.

More Unicycive Therapeutics Inc News Articles

North Bay Resources (PK)

Enzolytics (PK)

TPT Global Tech (CE)

TheGlobe com (PK)

NioCorp Developments

Elite Pharmaceuticals (QB)

Code Green Apparel (PK)

FuelCell Energy

Asia Broadband (PK)

Accredited Solutions (PK)

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions